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The basidiomycetous yeast Filobasidium capsuligenum (IFM 
40078) produces a killer toxin (FC-1) which is highly effec-
tive against the opportunistic fungal pathogen Cryptococcus 
neoformans. The sensitivities of strains representing eight 
molecular subtypes (VNI-IV and VGI-IV) of the C. neofor-
mans species complex, and of an additional 50 clinical and
environmental isolates were determined. Additionally fur-
ther yeast species were tested for toxin sensitivity, but FC-1 
showed strong specificity for Cryptococcus isolates, and 
did not affect the other examined yeast species. This highly 
specific effect is mainly characteristic to proteins. Several 
other observations such as the high thermolability of FC-1, 
the partial loss of activity in presence of proteases and the 
considerably narrow pH optimum (pH 4-6) also confirm the 
protein character of the toxin. Our goal was to characterise 
and clone the toxin encoding gene and to study the effect of 
the toxin on C. neoformans cells.
Neither RNA, nor DNA plasmids were detectable by 
agarose gel electrophoresis or pulse-field gel electrophoresis 
(OFAGE), thus the gene encoding the toxin is most likely 
located in the chromosomal DNA. 
Growing of Filobasidium capsuligenum (IFM40078) on 
complete media leads to toxin production, however on mini-
mal media no biological activity can be detected. In order 
to identify the toxin the extracellular enzyme profiles of the 
fungi were determined by polyacrylamide gel electrophoresis 
in both conditions. Comparison of the results showed that 
there are a large number of differences between the two pro-
files making it difficult to unambiguously identify the toxin. 
Similar observations were perceived when profiles of non-
producing Filobasidium capsuligenum strain (VKM1513) 
or non-producing mutant strains generated by UV mutagen-
esis were compared to the toxin containing profile of strain 
IFM40078. 
Results of competition assay suggest that β-1,6-glucan 
(pustulan) in the cell wall may provide the binding site for 
the killer protein. Taking advantage of this specific binding 
β-1,6-glucan was applied for affinity chromatography as a 
ligand to purify the toxin. Biologically active fractions from 
the pustulan-coupled epoxy-activated sepharose 6B column 
were loaded on polyacrylamid gel. A few proteins in the range 
of 19 - 51 kDa were detected. A 47 kDa protein, the best can-
didate for being the toxin, was sequenced (XVNVNGVPI). 
This sequence could be used for aquiring the coding DNA 
by reverse transcription.
Other, already characterised killer toxins have been used 
for homology searches to find conservative amino acid or 
nucleic acid regions. However no significant homology 
has been found among these proteins suggesting that such 
comparative studies do not serve as useful tools for further 
characterisation of the toxin. 
An effective approach for identifying the coding DNA 
can be the analysis of the toxin producing (IFM40078) and 
non-producing (VKM1513) strains at the mRNA level. By 
subtractive hybridisation cDNA segments differing in the 
two strains can be selectively amplified in order to find the 
toxin encodig gene.
To investigate the mechanism of the effect of the FC-1 
toxin-treated cells were studied. Analysis of cellular DNA by 
laser scanning cytometry and FITC staining revealed that the 
killing mechanism of FC-1 is neither cell cycle- nor cell wall 
biosynthesis-dependent; rather it might act as an ionophor that 
disrupts the cytoplasmic membrane function.
These various research tools could lead to the complete 
characterisation of the FC-1 anti-cryptococcal toxin which 
has the potential to be applied as a therapeutic agent for the 
treatment of cryptococcosis.
